Tecan Group AG (TECN) - Total Assets
Based on the latest financial reports, Tecan Group AG (TECN) holds total assets worth CHF1.94 Billion CHF (≈ $2.45 Billion USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Tecan Group AG - Total Assets Trend (2002–2024)
This chart illustrates how Tecan Group AG's total assets have evolved over time, based on quarterly financial data. Also see TECN market cap for the company's overall valuation and market capitalisation.
Tecan Group AG - Asset Composition Analysis
Current Asset Composition (December 2024)
Tecan Group AG's total assets of CHF1.94 Billion consist of 40.4% current assets and 59.6% non-current assets. Review TECN liabilities breakdown to assess the company's total debt and financial obligations.
| Asset Category | Amount (CHF) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CHF154.19 Million | 7.3% |
| Accounts Receivable | CHF195.78 Million | 9.2% |
| Inventory | CHF230.50 Million | 10.9% |
| Property, Plant & Equipment | CHF147.33 Million | 6.9% |
| Intangible Assets | CHF308.31 Million | 14.5% |
| Goodwill | CHF760.96 Million | 35.9% |
Asset Composition Trend (2002–2024)
This chart illustrates how Tecan Group AG's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See latest Tecan Group AG stock price today for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Tecan Group AG's current assets represent 40.4% of total assets in 2024, a decrease from 73.7% in 2002.
- Cash Position: Cash and equivalents constituted 7.3% of total assets in 2024, down from 25.7% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 49.0% of total assets, an increase from 8.0% in 2002.
- Asset Diversification: The largest asset category is goodwill at 35.9% of total assets.
Tecan Group AG Competitors by Total Assets
Key competitors of Tecan Group AG based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
HOYA CORP. ADR/ 1 O.N.
F:HYB0
|
Germany | €1.23 Trillion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥29.91 Billion |
|
Autek China Inc
SHE:300595
|
China | CN¥6.40 Billion |
|
QITIAN Technology Group Co Ltd
SHE:300061
|
China | CN¥1.17 Billion |
|
Vizionfocus Inc.
TW:4771
|
Taiwan | NT$7.44 Billion |
|
Amplitude Surgical SAS
PA:AMPLI
|
France | €279.66 Million |
|
Suzhou Iron Technology Co. Ltd. A
SHG:688329
|
China | CN¥1.36 Billion |
|
DIO Corporation
KQ:039840
|
Korea | ₩332.33 Billion |
Tecan Group AG - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.61 | 2.87 | 3.73 |
| Quick Ratio | 1.18 | 1.92 | 2.79 |
| Cash Ratio | 0.51 | 0.37 | 1.09 |
| Working Capital | CHF307.66 Million | CHF552.48 Million | CHF474.17 Million |
Tecan Group AG - Advanced Valuation Insights
This section examines the relationship between Tecan Group AG's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.32 |
| Latest Market Cap to Assets Ratio | 0.81 |
| Asset Growth Rate (YoY) | 2.3% |
| Total Assets | CHF2.12 Billion |
| Market Capitalization | $1.72 Billion USD |
Valuation Analysis
Near Book Valuation: The market values Tecan Group AG's assets close to their book value (0.81x), suggesting investors view the company's assets at approximately fair value.
Positive Asset Growth: Tecan Group AG's assets grew by 2.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Tecan Group AG (2002–2024)
The table below shows the annual total assets of Tecan Group AG from 2002 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CHF2.12 Billion ≈ $2.68 Billion |
+2.29% |
| 2023-12-31 | CHF2.07 Billion ≈ $2.62 Billion |
-4.00% |
| 2022-12-31 | CHF2.16 Billion ≈ $2.73 Billion |
+5.70% |
| 2021-12-31 | CHF2.04 Billion ≈ $2.58 Billion |
+80.79% |
| 2020-12-31 | CHF1.13 Billion ≈ $1.43 Billion |
+20.30% |
| 2019-12-31 | CHF939.77 Million ≈ $1.19 Billion |
+9.57% |
| 2018-12-31 | CHF857.67 Million ≈ $1.08 Billion |
+6.68% |
| 2017-12-31 | CHF803.96 Million ≈ $1.02 Billion |
+9.21% |
| 2016-12-31 | CHF736.16 Million ≈ $930.71 Million |
+14.76% |
| 2015-12-31 | CHF641.48 Million ≈ $811.01 Million |
+16.16% |
| 2014-12-31 | CHF552.26 Million ≈ $698.21 Million |
+18.35% |
| 2013-12-31 | CHF466.65 Million ≈ $589.97 Million |
+10.76% |
| 2012-12-31 | CHF421.30 Million ≈ $532.64 Million |
+8.04% |
| 2011-12-31 | CHF389.94 Million ≈ $492.99 Million |
+15.20% |
| 2010-12-31 | CHF338.50 Million ≈ $427.96 Million |
-2.90% |
| 2009-12-31 | CHF348.62 Million ≈ $440.75 Million |
+6.98% |
| 2008-12-31 | CHF325.86 Million ≈ $411.98 Million |
-12.87% |
| 2007-12-31 | CHF373.98 Million ≈ $472.81 Million |
+2.29% |
| 2006-12-31 | CHF365.60 Million ≈ $462.22 Million |
+8.16% |
| 2005-12-31 | CHF338.01 Million ≈ $427.33 Million |
+76.68% |
| 2004-12-31 | CHF191.31 Million ≈ $241.87 Million |
-14.69% |
| 2003-12-31 | CHF224.25 Million ≈ $283.51 Million |
-1.99% |
| 2002-12-31 | CHF228.81 Million ≈ $289.27 Million |
-- |
About Tecan Group AG
Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments, Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, NGS reagents, immunoassays and antibodies, … Read more